India Biobanking Market Overview, 2029

The biorepositories are important for the advancement of health understanding, personalized medical treatment and medical research. Biobanks enable studies on genetics, epidemiology, and translational research by giving investigators a source of exceptional biological samples, which eventually contribute to better healthcare results. The increasing incidence of persistent illnesses, scientific breakthroughs, and the growing need for personalised medication have all contributed to the enormous rise of the worldwide biobanking industry. The market is expanding due to advancements in biobanking technology, including automated storage systems and improved data management solutions. Furthermore, partnerships between academic institutions and biopharmaceutical businesses are promoting the creation of increasingly complex and varied biobanks. Additionally, the industry is seeing a trend towards artificial intelligence (AI) and virtual biobanks as ways to improve sample analysis and utilisation. The biobanking industry in India is progressively acquiring traction because to expanding research endeavours and government programmes meant to further biomedical research. The establishment of numerous governmental and private biobanks has strengthened the facilities for the gathering and storing of biological samples. Several challenges are faced during the time of expansion and advancement of the biobanking industry in India. The absence of standardized procedures and legal formalities is one of the main problems since it might result in discrepancies in sample quality and data management. Financial issue is one of major problem, because it takes a lot of money to develop and run biobanks. However, lack of knowledge, awareness to general public's and healthcare professionals is also consirederd as a major challenge. According to the research report "India Biobanking Market Overview, 2029," published by Bonafide Research, the India Biobanking market is anticipated to grow at more than 11.5% CAGR from 2024 to 2029. Major developments which are relay on personalized medicine in India, which gives medical treatments to individual patients based on their genetic makeup, lifestyle, and environmental factors. Trend has led to an increased demand for high-quality biological samples and associated data. Biobanks plays an important role in supporting customized medication by providing researchers and clinicians with access to diverse collections of samples for biomarker discovery, disease modeling, and treatment optimization. Frequently new advancements in biomedical research have fueled the demand for biological samples for basic research, translational studies, and clinical trials. Biobanks in India provide researchers with access to well-characterized samples and associated data, enabling investigations into disease mechanisms, identification of therapeutic targets, and evaluation of drug efficacy and safety.

The necessity for high-quality biological samples and the progress made in medical research have led to a notable expansion of the biobanking industry in India. This industry is divided into three product categories: laboratory computer systems, supplies, and equipments. A variety of specialised instruments required for the gathering, handling, and storing of biological samples are included in the category of equipment. This comprises centrifuges for processing samples, freezers, refrigerators, and liquid nitrogen tanks for cryopreservation, as well as biosafety cabinets to guarantee a contaminant-free environment. India's need for sophisticated biobanking operations equipment is expanding as a result of public and commercial initiatives to improve the nation's infrastructures for medical research. Tubes, vials, reagents, and other single-use items essential for sample processing and storage are among the consumables used in the Indian biobanking industry. These goods are necessary to avoid contamination and preserve sample integrity. great-quality consumables are in great demand due to the growing number of biobanks in India, and both domestic and foreign providers are vying to supply this demand. Another essential element is Laboratory Information Systems (LIS), which offer the software tools required for effective management and tracking of sample data. These platforms make sure that all paperwork is completed correctly, that regulations are followed, and that researchers can share data easily with one another. The use of LIS is growing in India as biobanks look to improve data security and operational efficiency in order to produce more dependable and efficient research results. The biobanking industry in India includes a range of service offerings that are tailored to meet specific demands of the research and medical sectors. The gathering, handling, and preservation of biological samples, such as blood, tissues, and DNA, are covered in the Biobanking and Repository section. These repositories are essential for advancing drug discovery, personalised medicine, and disease mechanism research in the biological sciences. Due to the growing significance of precision medicine and the rising incidence of chronic diseases, biobanks are becoming more and more common in healthcare facilities, laboratories, and private enterprises in India. The need for well-preserved, excellent specimens guarantees that biobanks play a crucial role in improving patient outcomes. The authenticity and usefulness of biobank sample depend heavily upon the Lab Processing and Validation/Qualification operations. Thorough testing and certification are required for validation and qualification. These facilities are necessary to transform biological materials in their raw form into data that can be used in scientific research. Cold Chain Logistics uses cutting edge technology to provide constant temperature regulation from sample collection to storage, which is essential to preserving the viability of samples during transit. There are major 2 types of Biobanks, such as real and virtual ones, they serve as the foundation for segmentation in India. Physical Biobank includes tissues, blood, cells, and DNA are tangible biological samples. Generally the samples are used for research, clinical trials, and diagnostic reasons, these biobanks include huge collections of samples drawn from patients, people, and groups. On the other hand Virtual biobanks, is working as keeping databases or registries with genetic information, clinical or phenotypic data gathered from people or patient cohorts, and anonyised which identified health information. India's biobanking industry which is in line with the nation's increasing focus on biomedical research and innovation in healthcare. Biobanks runs as a collection of biological specimens which are important for identifies disease mechanisms and discovering possible treatment in the fields of drug discovery and clinical research. These specimens, which consist of DNA, tissue, and blood, aid in the creation of novel medications and personalised treatment strategies. Indian biobanks facilitate the performance of preclinical research and clinical trials by pharmaceutical corporations and research institutions, hence expediting the drug development process. In the area of therapeutics and clinical diagnostics, Indian biobanks are important to enhancing patient care and treatment methods. Biobanks store stem cells and other regenerative materials that are used in the development of novel treatments for diseases such as cancer, heart disease, and genetic disorders. This is particularly very crucial in India, whereas chronic sickness is very common. Because they aid in the discovery of biomarkers and the development of diagnostic techniques that enable rapid and precise illness identification, biobanks are essential equipment in clinical diagnostics. Considered in this report • Historic year: 2018 • Base year: 2023 • Estimated year: 2024 • Forecast year: 2029 Aspects covered in this report • Biobanking market Outlook with its value and forecast along with its segments • Various drivers and challenges • On-going trends and developments • Top profiled companies • Strategic recommendation

By Product Type • Equipment • Consumables • Laboratory Information Systems By Service Type • Biobanking and Repository • Validation/Qualification • Lab Processing • Cold Chain Logistic • Others By Biospecimen Type • Human Tissues • Stem Cells • Organs • Others By Biobank • Physical Biobanks • Virtual Biobanks By Application • Drug Discovery and Clinical Research • Therapeutics • Clinical Diagnostics • Others By Type of Biobank • Population-based Biobanks • Disease-oriented Biobanks By Ownership • National/regional agency • Non-Profit Organization • Universities • Private Organization By Storage • Manual Storage • Automated Storage The approach of the report: This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources. Intended audience This report can be useful to industry consultants, manufacturers, suppliers, associations, and organizations related to the Biobanking industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.